| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/24/2003 | US20030077756 Identification and modification of immunodominant epitopes in polypeptides |
| 04/24/2003 | US20030077753 Diglycosylated erythropoietin |
| 04/24/2003 | US20030077752 Factor VIII glycoforms |
| 04/24/2003 | US20030077750 Peptide for use in human therapeutics and diagnostics |
| 04/24/2003 | US20030077749 Ucp5 |
| 04/24/2003 | US20030077744 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077743 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077742 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077741 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077739 Generation of preferential antibody; obtain nucleotide sequences coding antibody, insert into vector, transform vector into cell, express vector, recover antibody |
| 04/24/2003 | US20030077738 Nucleotide sequences coding polypeptide for use in the treatment of immunological disorders |
| 04/24/2003 | US20030077737 Compositions and methods for the treatment of immune related diseases |
| 04/24/2003 | US20030077736 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077735 Novel human Kchannel and therapeutic applications thereof |
| 04/24/2003 | US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/24/2003 | US20030077728 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077727 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077726 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077725 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077724 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077723 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077722 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077721 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077720 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077719 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077718 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077717 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077716 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077715 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077714 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077713 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077712 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077711 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077710 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077708 Antigen presenting system and methods for activation of T-cells |
| 04/24/2003 | US20030077706 Mouse cytokine receptor |
| 04/24/2003 | US20030077705 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and ischemia-reperfusion injury |
| 04/24/2003 | US20030077704 Nucleotide sequences coding polypeptide for use in the treatment and detection of cell proliferative and respiratory disorders |
| 04/24/2003 | US20030077703 Nucleic acids, proteins, and antibodies |
| 04/24/2003 | US20030077702 Preparing gnetically engineered glucose oxidase; obtain nucleotide sequence coding glucose oxidase, mutate sequence, insert into vector, transform cells, propagate cells, express vector, monitor glucose oxidase expression |
| 04/24/2003 | US20030077700 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system amd liver disordrs |
| 04/24/2003 | US20030077698 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077694 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |
| 04/24/2003 | US20030077663 Antibody discriminates between active and inactive conformations of growth hormone receptor |
| 04/24/2003 | US20030077659 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorders |
| 04/24/2003 | US20030077657 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077654 Nucleotide sequences coding polypeptide for use in the treatment of nephritis, cancer and skin disorders |
| 04/24/2003 | US20030077606 Nucleic acids, proteins, and antibodies |
| 04/24/2003 | US20030077602 Nucleic acids, proteins, and antibodies |
| 04/24/2003 | US20030077594 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 04/24/2003 | US20030077593 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077583 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077568 Screening drugs; obtain cell with preferential phenotypic profile, incubate with drug, monitor effect on cells |
| 04/24/2003 | US20030077318 Activation lymphocytes; therapy for aids, cancer; immobilization on solid support |
| 04/24/2003 | US20030077294 Proteinaceous material associated with adenylate cyclase activity in cultures of Bordetella pertussis; useful as components of acellular whooping cough vaccines |
| 04/24/2003 | US20030077292 Detection and treatment of cancers of the lung |
| 04/24/2003 | US20030077287 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 04/24/2003 | US20030077285 Methods of diagnosis and treatment by binding p75/airm1 |
| 04/24/2003 | US20030077281 Immunointeractive molecules and uses therefor |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077277 Human antibodies that have MN binding and cell adhesion-neutralizing activity |
| 04/24/2003 | US20030077276 Expression vectors constructed by inserting antibody heavy chain variable region-encoding cDNA and antibody light chain variable region-encoding cDNA isolated from hybridomas producing rat onoclonal antibody reacting with ganglioside gm2 |
| 04/24/2003 | US20030077275 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 04/24/2003 | US20030077260 Hybrid matrix implants and explants |
| 04/24/2003 | US20030077248 Treating cancer with a culture product from a non-naturally occurring antigen-presenting cell; polyclonal antibodies expression |
| 04/24/2003 | CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | CA2463943A1 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/24/2003 | CA2463931A1 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 04/24/2003 | CA2463927A1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | CA2463914A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 04/24/2003 | CA2463672A1 Direct targeting binding proteins |
| 04/24/2003 | CA2463634A1 Anti-hla-dr antibody |
| 04/24/2003 | CA2463492A1 Methods for the treatment of carcinoma |
| 04/24/2003 | CA2463167A1 Production, detection and use of transformant cells |
| 04/24/2003 | CA2463003A1 Dimerized growth factor and materials and methods for producing it |
| 04/24/2003 | CA2462785A1 Kinases and phosphatases |
| 04/24/2003 | CA2461818A1 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | CA2461575A1 Use of peptide vectors to improve the immune response to antigens |
| 04/24/2003 | CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | CA2454578A1 Modified human thymic stromal lymphopoietin |
| 04/23/2003 | EP1304381A2 Process for producing hydrophobic polypeptides, proteins or peptides |
| 04/23/2003 | EP1304379A2 Humanised antibody against CD18 |
| 04/23/2003 | EP1304376A1 Process for producing recombinant protein |
| 04/23/2003 | EP1304375A1 Method of preparing antibody by gene immunization |
| 04/23/2003 | EP1304336A2 Antibodies for specific detection of pathogenic prions of human origin and detection methods using them |
| 04/23/2003 | EP1303625A2 Alpha-msh related compounds and methods of use |
| 04/23/2003 | EP1303621A2 Novel cacao endoproteinases and their use in the production of cocoa flavour |
| 04/23/2003 | EP1303612A2 Streptococcus antigens |
| 04/23/2003 | EP1303611A2 Novel protein containing ring finger domaine r1p4 |
| 04/23/2003 | EP1303608A2 Zinc finger domain recognition code and uses thereof |
| 04/23/2003 | EP1303607A2 High affinity soluble interleukin-18 receptor |
| 04/23/2003 | EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/23/2003 | EP1303594A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 04/23/2003 | EP1303592A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 04/23/2003 | EP1303539A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303535A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 04/23/2003 | EP1303530A2 CLONING AND PRODUCING THE N. i Bst /i NBI NICKING ENDONUCLEASE AND RELATED METHODS FOR USING NICKING ENDONUCLEASES IN SINGLE-STRANDED DISPLACEMENT AMPLIFICATION |
| 04/23/2003 | EP1057033B1 Treating cancer |